Literature DB >> 21762360

Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: the REGARDS study.

Paul Muntner1, Jewell H Halanych, Kristi Reynolds, Raegan Durant, Suma Vupputuri, Victor W Sung, James F Meschia, Virginia J Howard, Monika M Safford, Marie Krousel-Wood.   

Abstract

The authors analyzed data on 9950 participants taking antihypertensive medications in the nationwide Reasons for Geographic and Racial Differences in Stroke (REGARDS) study to determine the association between medication adherence and incident stroke symptoms. Medication adherence was assessed using a validated 4-item self-report scale and participants were categorized into 4 groups (scores of 0, 1, 2, and 3 or 4, with higher scores indicating worse adherence). The incidence of 6 stroke symptoms (sudden weakness on one side of the body, numbness, painless loss of vision in one or both eyes, loss of half vision, losing the ability to understand people, and losing the ability to express oneself verbally or in writing) was assessed via telephone interviews every 6 months. During a median of 4 years, the incidence of any stroke symptom was 14.6%, 17.9%, 20.2%, and 24.9% among participants with adherence scores of 0, 1, 2, and 3 or 4, respectively (P<.001). The multivariable adjusted hazard ratio (95% confidence interval) for any stroke symptom associated with adherence scores of 1, 2, and 3 or 4, vs 0, was 1.20 (1.04-1.39), 1.23 (0.94-1.60), and 1.59 (1.08-2.33), respectively (P<.001). Worse adherence was also associated with higher multivariable adjusted hazard ratios for each of the 6 stroke symptoms.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762360      PMCID: PMC3140118          DOI: 10.1111/j.1751-7176.2011.00464.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

1.  Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning.

Authors:  George Howard; Monika M Safford; James F Meschia; Claudia S Moy; Virginia J Howard; LeaVonne Pulley; Camilo R Gomez; Martha Crowther
Journal:  Stroke       Date:  2007-08-02       Impact factor: 7.914

Review 2.  A meta-analysis of the association between adherence to drug therapy and mortality.

Authors:  Scot H Simpson; Dean T Eurich; Sumit R Majumdar; Rajdeep S Padwal; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2006-06-21

3.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

Review 4.  Methods to improve medication adherence in patients with hypertension: current status and future directions.

Authors:  Marie Krousel-Wood; Amanda Hyre; Paul Muntner; Donald Morisky
Journal:  Curr Opin Cardiol       Date:  2005-07       Impact factor: 2.161

5.  Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. The ARIC Study, 1987-1989.

Authors:  L E Chambless; E Shahar; A R Sharrett; G Heiss; L Wijnberg; C C Paton; P Sorlie; J F Toole
Journal:  Am J Epidemiol       Date:  1996-11-01       Impact factor: 4.897

6.  High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.

Authors:  Virginia J Howard; Leslie A McClure; James F Meschia; Leavonne Pulley; Sean C Orr; Gary H Friday
Journal:  Arch Intern Med       Date:  2006-10-09

7.  Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.

Authors:  Paul Muntner; Karen B DeSalvo; Rachel P Wildman; Paolo Raggi; Jiang He; Paul K Whelton
Journal:  Am J Epidemiol       Date:  2006-04-05       Impact factor: 4.897

8.  Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention.

Authors:  Fatima-Zohra Kettani; Alice Dragomir; Robert Côté; Louise Roy; Anick Bérard; Lucie Blais; Lyne Lalonde; Pierre Moreau; Sylvie Perreault
Journal:  Stroke       Date:  2008-11-26       Impact factor: 7.914

9.  Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting.

Authors:  Amanda D Hyre; Marie A Krousel-Wood; Paul Muntner; Lumie Kawasaki; Karen B DeSalvo
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-03       Impact factor: 3.738

10.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

View more
  16 in total

1.  Hypertension: ACE inhibitor use in pregnancy--setting the record straight.

Authors:  Gideon Koren
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

2.  Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension.

Authors:  Marguerite R Irvin; Daichi Shimbo; Devin M Mann; Kristi Reynolds; Marie Krousel-Wood; Nita A Limdi; Daniel T Lackland; David A Calhoun; Suzanne Oparil; Paul Muntner
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

3.  Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.

Authors:  Maxwell D Anderegg; Tyler H Gums; Liz Uribe; Christopher S Coffey; Paul A James; Barry L Carter
Journal:  Hypertension       Date:  2016-09-06       Impact factor: 10.190

Review 4.  Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study).

Authors:  Paul Muntner; Marwah Abdalla; Adolfo Correa; Michael Griswold; John E Hall; Daniel W Jones; George A Mensah; Mario Sims; Daichi Shimbo; Tanya M Spruill; Katherine L Tucker; Lawrence J Appel
Journal:  Hypertension       Date:  2017-03-20       Impact factor: 10.190

5.  Using mHealth Tools to Improve Rural Diabetes Care Guided by the Chronic Care Model.

Authors:  Jennifer A Mallow; Laurie A Theeke; Emily R Barnes; Tara Whetsel; Brian K Mallow
Journal:  Online J Rural Nurs Health Care       Date:  2014

6.  Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.

Authors:  Valeria Avataneo; Amedeo De Nicolò; Franco Rabbia; Elisa Perlo; Jacopo Burrello; Elena Berra; Marco Pappaccogli; Jessica Cusato; Antonio D'Avolio; Giovanni Di Perri; Franco Veglio
Journal:  Br J Clin Pharmacol       Date:  2018-08-15       Impact factor: 4.335

7.  In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

Authors:  Katrin Krueger; Nina Griese-Mammen; Ingrid Schubert; Marita Kieble; Lea Botermann; Ulrich Laufs; Charlotte Kloft; Martin Schulz
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

Review 8.  Electronic medication packaging devices and medication adherence: a systematic review.

Authors:  Kyle D Checchi; Krista F Huybrechts; Jerry Avorn; Aaron S Kesselheim
Journal:  JAMA       Date:  2014-09-24       Impact factor: 56.272

9.  Access to Care, Treatment Ambivalence, Medication Nonadherence, and Long-Term Mortality Among Severely Hypertensive African Americans: A Prospective Cohort Study.

Authors:  J Hunter Young; Derek Ng; Chidinma Ibe; Kristina Weeks; Daniel J Brotman; Sydney Morss Dy; Frederick L Brancati; David M Levine; Michael J Klag
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-29       Impact factor: 3.738

10.  Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States.

Authors:  Chris LaVallee; Karen L Rascati; Tyler H Gums
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-09-20       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.